Real-World Efficacy of Cadonilimab Plus Chemotherapy as Second-Line Therapy in Immunotherapy-Pretreated Advanced HER2 Negative Gastric or Gastroesophageal Junction Cancer
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s548735 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Zeyu Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000, People's Republic of China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Esophagogastric Junction, Esophageal Neoplasms, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, 264000, People's Republic of China.
ORCID-Profile: Jinyu Xiang
Zitieren
APA
Liu, Z., Lu, Y., Li, M., Xiang, J., Sun, P., & Liu, A. (2025). Real-World Efficacy of Cadonilimab Plus Chemotherapy as Second-Line Therapy in Immunotherapy-Pretreated Advanced HER2 Negative Gastric or Gastroesophageal Junction Cancer. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s548735
Vancouver
Liu Z, Lu Y, Li M, Xiang J, Sun P, Liu A. Real-World Efficacy of Cadonilimab Plus Chemotherapy as Second-Line Therapy in Immunotherapy-Pretreated Advanced HER2 Negative Gastric or Gastroesophageal Junction Cancer. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s548735
BibTeX
@article{Liu2025,
author = {Liu, Zeyu and Lu, Yuxiao and Li, Ming and Xiang, Jinyu and Sun, Ping and Liu, Aina},
title = {Real-World Efficacy of Cadonilimab Plus Chemotherapy as Second-Line Therapy in Immunotherapy-Pretreated Advanced HER2 Negative Gastric or Gastroesophageal Junction Cancer},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s548735}
}
EUVIMED